Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph

Otology and Neurotology

Volumn 32, Issue 6, 2011, Pages 933-936

  Bird, Philip A ^a,b   Murray, Daran P ^a   Zhang, Mei ^b   Begg, Evan J ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Cochlea; Dexamethasone; Intratympanic; Intravenous; Perilymph

Indexed keywords

DEXAMETHASONE; DEXAMETHASONE 21-PHOSPHATE; DEXAMETHASONE SODIUM PHOSPHATE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; EARDRUM; FEMALE; HUMAN; INJECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MIDDLE EAR; PERILYMPH;

ADOLESCENT; ADULT; AGED; DEXAMETHASONE; EAR, MIDDLE; FEMALE; HUMANS; INJECTIONS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PERILYMPH; TYMPANIC MEMBRANE;

EID: 80051736576     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3182255933     Document Type: Article

References (11)

1. Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007;28:1124-30. (Pubitemid 350191089)
2. Plontke SK, Mikulec AA, Salt AN. Rapid clearance of methylprednisolone after intratympanic application in humans. Comment: Bird PA, Begg EJ, Zhang M, et al. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph; Otol Neurotol 2007;28:1124-30. Otol Neurotol 2008;29:732-4.
3. Parnes LS, Sun A, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: An animal study followed by clinical application. Layngoscope 1999;109:1-17. (Pubitemid 29315126)
4. Chandrasekhar SS, Rubinstein RY, Kwartler JA, et al. Dexamethasone pharmacokinetics in the inner ear: Comparisons of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521-8. (Pubitemid 30210667)
5. Zhang M, Moore GA, Jensen BP, Begg EJ, Bird PA. Determination of dexamethasone and dexamethasone sodium phosphate in human plasma and cochlear perilymph by liquid chromatography/tandem mass spectrometry. J Chromatogr B 2011;879:17-24.
6. Eshraghi A, Adil E, He J, Graves R, Balkany TJ, Van De Water TR. Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 2007;28:842-9. (Pubitemid 47329902)
7. Chang A, Eastwood H, Sly D, James D, Richardson R, O'Leary S. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hear Res 2009;255:67-72.
8. James DP, Eastwood H, Richardson RT, O'Leary SJ. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurotol 2008;13:86-96. (Pubitemid 351225887)
9. Kiefer J, Gstoettner Baumgartner W, Pok SM, Tellein J, Ye Q, Von Ilberg C. Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272-80. (Pubitemid 38580856)
10. Vivero RJ, Joseph DE, Angeli S, et al. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 2008;118:2028-35.
11. Connolly TM, Eastwood H, Kel G, Lisnichuk H, Richardson R, O'Leary S. Pre-operative intravenous dexamethasone prevents auditory threshold shift in a guinea pig model of cochlear implantation. Audiol Neurotol 2011;16:137-44 (DOI: 10.1159/000314757).